Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/197465
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Campo DC Valor Lengua/Idioma
dc.contributor.authorBallestero-Téllez, Mónicaes_ES
dc.contributor.authorDocobo-Pérez, Fernandoes_ES
dc.contributor.authorPortillo-Calderón, Inéses_ES
dc.contributor.authorRodríguez-Martínez, José-Manueles_ES
dc.contributor.authorRacero, L.es_ES
dc.contributor.authorRamos-Guelfo, M. S.es_ES
dc.contributor.authorBlázquez Gómez, Jesúses_ES
dc.contributor.authorRodríguez-Baño, Jesúses_ES
dc.contributor.authorPascual, Álvaroes_ES
dc.date.accessioned2020-01-07T14:07:45Z-
dc.date.available2020-01-07T14:07:45Z-
dc.date.issued2017-05-
dc.identifier.citationJournal of Antimicrobial Chemotherapy 72(5): 1303-1309 (2017)es_ES
dc.identifier.issn0305-7453-
dc.identifier.urihttp://hdl.handle.net/10261/197465-
dc.description.abstract[Objectives] Fosfomycin activity in Escherichia coli depends on several genes of unknown importance for fosfomycin resistance. The objective was to characterize the role of uhpT, glpT, cyaA and ptsI genes in fosfomycin resistance in E. coli.es_ES
dc.description.abstract[Methods] WT E. coli BW25113 and null mutants, ΔuhpT, ΔglpT, ΔcyaA, ΔptsI, ΔglpT-uhpT, ΔglpT-cyaA, ΔglpT-ptsI, ΔuhpT-cyaA, ΔuhpT-ptsI and ΔptsI-cyaA, were studied. Susceptibility to fosfomycin was tested using CLSI guidelines. Fosfomycin mutant frequencies were determined at concentrations of 64 and 256 mg/L. Fosfomycin in vitro activity was tested using time–kill assays at concentrations of 64 and 307 mg/L (human Cmax).es_ES
dc.description.abstract[Results] Fosfomycin MICs were: WT E. coli BW25113 (2 mg/L), ΔglpT (2 mg/L), ΔuhpT (64 mg/L), ΔcyaA (8 mg/L), ΔptsI (2 mg/L), ΔglpT-uhpT (256 mg/L), ΔglpT-cyaA (8 mg/L), ΔglpT-ptsI (2 mg/L), ΔuhpT-cyaA (512 mg/L), ΔuhpT-ptsI (64 mg/L) and ΔptsI-cyaA (32 mg/L). In the mutant frequency assays, no mutants were recovered from BW25113. Mutants appeared in ΔglpT, ΔuhpT, ΔcyaA and ΔptsI at 64 mg/L and in ΔuhpT and ΔcyaA at 256 mg/L. ΔglpT-ptsI, but not ΔglpT-cyaA, ΔuhpT-cyaA or ΔuhpT-ptsI, increased the mutant frequency compared with the highest frequency found in each single mutant. In time–kill assays, all mutants regrew at 64 mg/L. Initial bacterial reductions of 2–4 log10 cfu/mL were observed for all strains, except for ΔuhpT-ptsI, ΔglpT-uhpT and ΔuhpT-cyaA. Only ΔglpT and ΔptsI mutants were cleared using 307 mg/L.es_ES
dc.description.abstract[Conclusions] Fosfomycin MIC may not be a good efficacy predictor, as highly resistant mutants may appear, depending on other pre-existing mutations with no impact on MIC.es_ES
dc.description.sponsorshipThis work was supported by the Ministerio de Economía y Competitividad, Instituto de Salud Carlos III (PI13/01885 and PI 13/01282) and the Consejería de Igualdad, Salud y Políticas Sociales, Junta de Andalucía (PI-0044-2013), Spain. It was partly supported by the Plan Nacional de I + D+i and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD12/0015)—co-financed by the European Development Regional Fund ‘A way to achieve Europe’ ERDF. F. D.-P. is supported by a VPPI-US fellowship from the University of Sevilla.es_ES
dc.language.isoenges_ES
dc.publisherOxford University Presses_ES
dc.rightsclosedAccesses_ES
dc.titleMolecular insights into fosfomycin resistance in Escherichia colies_ES
dc.typeartículoes_ES
dc.identifier.doi10.1093/jac/dkw573-
dc.description.peerreviewedPeer reviewedes_ES
dc.relation.publisherversionhttps://doi.org/10.1093/jac/dkw573es_ES
dc.identifier.e-issn1460-2091-
dc.contributor.funderMinisterio de Economía y Competitividad (España)es_ES
dc.contributor.funderInstituto de Salud Carlos IIIes_ES
dc.contributor.funderJunta de Andalucíaes_ES
dc.contributor.funderRed Española de Investigación en Patología Infecciosaes_ES
dc.contributor.funderEuropean Commissiones_ES
dc.contributor.funderUniversidad de Sevillaes_ES
dc.relation.csices_ES
oprm.item.hasRevisionno ko 0 false*
dc.identifier.funderhttp://dx.doi.org/10.13039/501100000780es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100003329es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100004587es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/100009042es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100011011es_ES
dc.type.coarhttp://purl.org/coar/resource_type/c_6501es_ES
item.cerifentitytypePublications-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairetypeartículo-
Aparece en las colecciones: (IBIS) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
accesoRestringido.pdf59,24 kBAdobe PDFVista previa
Visualizar/Abrir
Show simple item record

CORE Recommender

SCOPUSTM   
Citations

34
checked on 11-may-2024

WEB OF SCIENCETM
Citations

32
checked on 25-feb-2024

Page view(s)

224
checked on 16-may-2024

Download(s)

26
checked on 16-may-2024

Google ScholarTM

Check

Altmetric

Altmetric


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.